Pop Health Tech

How data could spur cost savings in treating a disease that's expected to cost $14.7B per year.

As participants like Apple and Samsung prepare to huddle, Pear Therapeutics sees the upside.

The man who ran Medicare and Medicaid under President Obama speaks out.

The work is so inspiring, Laura Adams said, that sometimes she wishes she did not have to sleep.

The CEO of the Rhode Island Quality Institute described fee-for-service as a "toxic payment model."

Adams discusses how Rhode Island Quality Institute's efforts towards a statewide health information database have been applied to the opioid crisis.

The unit will be capable of producing up to a billion genetically-modified mosquito eggs per week.

Two physicians from UCSF call on the medical Accreditation Council to raise the bar on how it determines physicians can be trained.

"It improves how kidneys are allocated, and it improves the rationalizations of doctors and patients."

As Amazon threatens both retail sales and a pharmacy play, Target seems to intent on building its own retail-pharmacy-provider ecosystem.

Pager CEO Walter Jin spoke to Healthcare Analytics News about the goals of the partnership and his company's AI integration.

The plans could be of benefit to those with chronic conditions that require recurring clinical visits.

Detecting an infectious disease is almost, by definition, an after-the-fact-activity, but halting its spread is more possible than ever.

This marks the first use of micromotor technology to treat disease in a living organism.

The FDA, for the first time, approved a gene therapy with a good chance of bringing remission for young cancer patients.

Data analytics and accountability are key, according to researchers at Oregon Health and Sciences University.

Apparently “come to us, we have no infections,” doesn’t qualify as adequate reporting.

Reports, initiatives, and investments made August a big month for the growing field.

For many providers, MACRA is either enigmatic or nightmarish. A new survey from NueMD shows the depth of uncertainty.

Behavioral health telehealth provider adds Bain Capital and Aetna to its list of backers.

“It’s a powerful tool...You can literally build an app in an hour and publish it,” Brian Well said.

The language regarding EMRs and MACRA at large was fairly straightforward during a panel at the Philadelphia HIT Summit.

The findings are particularly relevant in light of the 21st Century Cures Act implemented last December and the Right to Try Act approved by the Senate last week.

Predictive modeling may add a layer of protection against the common virus.

The firms utilized everything from novel devices to advanced analytics to dogs.